Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. CRVL
CRVL logo

CRVL Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
62.980
Open
60.850
VWAP
60.39
Vol
246.92K
Mkt Cap
3.01B
Low
58.780
Amount
14.91M
EV/EBITDA(TTM)
16.36
Total Shares
50.69M
EV
2.86B
EV/OCF(TTM)
18.39
P/S(TTM)
3.29
CorVel Corporation applies technology, including artificial intelligence, machine learning and natural language processing, to enhance the management of episodes of care and the related health-care costs. The Company partners with employers, third-party administrators, insurance companies and government agencies to assist its customers in managing the medical costs of workers compensation, group health and auto insurance, and in monitoring the quality of care provided to claimants. Its services include claims management, bill review, preferred provider networks, utilization management, case management, pharmacy services, directed care and Medicare services. It delivers its solutions in three ways - as a fully integrated claims-management program, as discrete standalone services, or as targeted add-ons that enhance an existing client workflow. Integrated, end-to-end bundled programs are designed primarily for buyers such as self-insured employers who want a single, turnkey partner.
Show More

Events Timeline

(ET)
2026-05-20
06:20:00
Q4 Revenue Reaches $248.54M
select
2026-02-03 (ET)
2026-02-03
06:20:00
Q3 Revenue Reaches $236M vs. $228M Last Year
select
2025-02-13 (ET)
2025-02-13
06:36:59
CorVel appoints Scott as Executive Vice President of Product
select
2024-12-24 (ET)
2024-12-24
12:16:10
CorVel announces effectiveness of three-for-one forward stock split
select
2024-12-13 (ET)
2024-12-13
15:17:39
CorVel announces three-for-one forward stock split
select
2024-11-29 (ET)
2024-11-29
12:31:08
CorVel chairman Clemons to retire, CEO Combs named next chairman
select
2024-08-27 (ET)
2024-08-27
07:43:28
CERIS announces advancements to FWA solutions
select

News

NASDAQ.COM
8.5
05-24NASDAQ.COM
Owls Nest Acquires Additional Shares in CorVel
  • Share Acquisition: Owls Nest acquired 348,329 shares of CorVel in Q1 2026, with an estimated trade value of $20.06 million, indicating confidence in the company despite recent stock declines.
  • AUM Growth: This transaction resulted in a 7.02% increase in Owls Nest's 13F reportable AUM, reflecting the effectiveness of its investment strategy in the healthcare management sector.
  • Financial Performance: CorVel reported a 7% revenue increase to $959 million for fiscal 2026, with diluted earnings per share rising 17%, showcasing strong performance in the insurance and risk management space.
  • Market Outlook: Growing demand for CorVel's healthcare payment accuracy platform, CERIS, is expected to provide greater revenue visibility, indicating that the company's strategic focus on innovation and operational efficiency is beginning to pay off.
Fool
8.5
05-24Fool
Owls Nest Partners Acquires New Position in CorVel
  • New Position Disclosure: On May 14, 2026, Owls Nest Partners IA disclosed a new holding of 348,329 shares of CorVel (CRVL), with an estimated transaction value of $20.06 million, reflecting confidence in the company's potential.
  • Asset Management Significance: CorVel now accounts for 6.66% of Owls Nest's reportable AUM, indicating its growing importance in the investment portfolio, which may influence future investment strategies.
  • Financial Performance: CorVel's fiscal 2026 revenue rose by 7% to $959 million, while diluted earnings per share increased by 17% to $2.14, demonstrating the company's ability to grow even in challenging market conditions, attracting investor interest.
  • Market Outlook: Despite a 45% decline in stock price, CorVel has secured several large clients for its healthcare payment accuracy platform, CERIS, which is expected to enhance future revenue visibility, underscoring the company's competitiveness in healthcare cost management.
Yahoo Finance
9.5
05-20Yahoo Finance
CorVel Reports Strong Financial Performance for FY 2026
  • Quarterly Revenue Growth: CorVel's revenue for the March quarter reached $249 million, marking a 7% increase from $232 million in the same period last year, indicating strong market performance and reinforcing its industry position.
  • Earnings Per Share Increase: The quarterly EPS rose from $0.51 to $0.61, a 19.6% increase, reflecting a significant enhancement in profitability that may attract more investor interest.
  • Annual Net Income Growth: The net income for FY 2026 was $110 million, a 14% increase over FY 2025, demonstrating the company's success in cost control and efficiency improvements, thereby enhancing its future growth potential.
  • Share Repurchase Program: CorVel repurchased 872,744 shares at a cost of $56 million during FY 2026, showcasing confidence in its own value while also providing additional returns to shareholders.
seekingalpha
9.5
05-20seekingalpha
CorVel Reports Q4 Fiscal 2026 Earnings with Strong Growth Indicators
  • Significant Revenue Growth: CorVel's Q4 fiscal 2026 revenue reached $249 million, a 7% increase year-over-year, indicating robust market performance that is expected to further enhance future profitability.
  • Earnings Per Share Increase: The earnings per share for the fourth quarter was $0.61, up 19.6% from $0.51 in the same period last year, reflecting improved profitability that may attract more investor interest.
  • Surge in New Bookings: New bookings increased by 56% year-over-year, with RFP activity rising by 20%, indicating strong momentum in market demand that is expected to significantly support revenue growth in the second half of the year.
  • Strategic Investment and Risk Management: CorVel's ongoing investments in AI and automation aim to enhance operational efficiency, while management highlighted risks related to cybersecurity and rising medical costs, demonstrating a commitment to growth alongside risk control and sustainable development.
NASDAQ.COM
2.0
05-20NASDAQ.COM
CorVel (CRVL) Q4 2026 Earnings Call Transcript
seekingalpha
9.5
05-20seekingalpha
CorVel Reports Strong Q4 Earnings with Revenue Growth
  • Earnings Highlights: CorVel reported a GAAP EPS of $0.61 for Q4, with revenue reaching $248.55 million, reflecting a 7.4% year-over-year growth that underscores the company's robust growth trajectory and boosts investor confidence.
  • Cash Position: At the end of the quarter, CorVel exited with $233 million in cash and cash equivalents, with no borrowings, providing a solid financial foundation for future investments and expansions.
  • Stock Buyback: The company repurchased $20.1 million of common stock during the quarter, indicating management's confidence in the company's future prospects while also enhancing earnings per share and shareholder value.
  • Growth Potential: With ongoing market growth and strong financial performance, CorVel is expected to continue benefiting from industry recovery and increasing market demand, further solidifying its market position.

Valuation Metrics

The current forward P/E ratio for CorVel Corp (CRVL.O) is 23.75, compared to its 5-year average forward P/E of 94.82. For a more detailed relative valuation and DCF analysis to assess CorVel Corp's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
94.82
Current PE
23.75
Overvalued PE
130.05
Undervalued PE
59.59

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
6.82
Current PS
0.00
Overvalued PS
8.77
Undervalued PS
4.87

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

Qué acciones tienen el rsi por debajo de 30
Intellectia · 288 candidates
Region: USRsi Category: oversoldList Exchange: XNYS, XNAS, XASE
Ticker
Name
Market Cap$
top bottom
SMWB logo
SMWB
Similarweb Ltd
336.50M
SSKN logo
SSKN
Strata Skin Sciences Inc
1.86M
UGRO logo
UGRO
urban-gro Inc
2.43M
GSHD logo
GSHD
Goosehead Insurance Inc
1.87B
ENSC logo
ENSC
Ensysce Biosciences Inc
1.58M
SLND logo
SLND
Southland Holdings Inc
81.17M

Whales Holding CRVL

K
Kayne Anderson Rudnick Investment Management, LLC
Holding
CRVL
-7.26%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is CorVel Corp (CRVL) stock price today?

The current price of CRVL is 59.4 USD — it has decreased -2.7

What is CorVel Corp (CRVL)'s business?

CorVel Corporation applies technology, including artificial intelligence, machine learning and natural language processing, to enhance the management of episodes of care and the related health-care costs. The Company partners with employers, third-party administrators, insurance companies and government agencies to assist its customers in managing the medical costs of workers compensation, group health and auto insurance, and in monitoring the quality of care provided to claimants. Its services include claims management, bill review, preferred provider networks, utilization management, case management, pharmacy services, directed care and Medicare services. It delivers its solutions in three ways - as a fully integrated claims-management program, as discrete standalone services, or as targeted add-ons that enhance an existing client workflow. Integrated, end-to-end bundled programs are designed primarily for buyers such as self-insured employers who want a single, turnkey partner.

What is the price predicton of CRVL Stock?

Wall Street analysts forecast CRVL stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for CRVL is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is CorVel Corp (CRVL)'s revenue for the last quarter?

CorVel Corp revenue for the last quarter amounts to 248.55M USD, increased 7.36

What is CorVel Corp (CRVL)'s earnings per share (EPS) for the last quarter?

CorVel Corp. EPS for the last quarter amounts to 0.61 USD, increased 19.61

How many employees does CorVel Corp (CRVL). have?

CorVel Corp (CRVL) has 5239 emplpoyees as of May 28 2026.

What is CorVel Corp (CRVL) market cap?

Today CRVL has the market capitalization of 3.01B USD.